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Pemphigus vulgaris (PV) is an autoimmune disease
mediated by autoantibodies against desmoglein-3
(Dsg3). It has been documented that both humoral and
cellular autoimmunity play essential roles in the devel-
opment of PV. Recently, we identi¢ed that Tcells from
PV patients respond to three antigenic fragments on the
ectodomain of Dsg3. These T cells are CD4 a/b cells se-
creting a Th2-like cytokine pro¢le, and responding of
Dsg3 in a restriction to HLA-DRBI0402 or 1401 alleles.
Other characteristics of these cells, such as detailed epi-
tope(s) and T cell receptors (TCRs) usage, however,
have not been investigated. The purpose of this study is
to determine detailed T cell epitope(s) and TCR genes
utilized by Dsg3-speci¢c T cells. Here, we found that
Dsg3(AA145-192)-speci¢c cells preferentially utilize
the TCRVb13 gene, while Dsg3(AA240-303)- and Dsg3
(AA570-614)-speci¢c cells utilize Vb7 and Vb17 genes,
respectively. Analysis of TCRVagene expression, it ap-
pears that Va22 gene is expressed by Dsg3(AA145-192)-
speci¢c cells, whereas the Va10 gene is predominantly
utilized by Dsg3(AA240-303)-speci¢c T cells. There are
no speci¢c utilization of Va gene in the group of cells
proliferate to Dsg3 (AA570-614).We believe that this in-
formation will further our understanding of the proper-
ties of autoimmune T cells in patients with PV. Key
words: autoimmunity/desmosome/gene rearrangement. J Invest
Dermatol 121:1365 ^1372, 2003
T
cell receptor (TCR) is a heterodimer composed of
either a and b or g and d chains (Wilson et al, 1988).
In man, the great majority of Tcells express abTCR,
whereas a minor population of T cells express gd
TCR. Antigen recognition and activation of T lym-
phocytes require the presentation of antigenic peptides by major
histocompatibility complex (MHC) on antigen-presenting cells
to the TCR (Hamano et al, 1992). Through the molecular interac-
tion between MHC/peptide and TCR and engagement of acces-
sory molecules, the antigen-speci¢c T cells are stimulated to
further their immunologic activities such as promoting antibody
production or destruction of target cells depending on their de-
signated functions. Based on its protein structure, TCR is cate-
gorized as a member of the immunoglobulin (Ig) superfamily
(Novotny et al, 1986; Chothia et al, 1988; Bentley et al, 1995). Each
chain of a TCR has at least three domains, one variable (V), one
joining ( J), and one constant (C) domain, which resemble the V,
J, and C regions of the Ig, respectively. Each TCR domain is
looped by an intrachain disul¢de bond, whereas the two dimers
are linked by an interchain disul¢de bond. In abTcells, although
the a chain of TCR is thought to contribute to the antigen re-
cognition, the b chain is the molecule that plays the most impor-
tant role in determining the antigenic speci¢city of Tcells.This is
evidenced by the fact that the crystal structure analysis reveals
that the three complementarity-determining regions are oriented
in the V domain of the b chain to form an antigen-binding site.
Complementarity-determining region 1 and complementarity-
determining region 2 of TCR form the anchor of the antigen-
binding region and contact the a-helical regions of the MHC
molecule, whereas its complementarity-determining region 3,
which is made up by the juncture of V, D (diversity), and J
regions, situates in the center of the antigen-binding site and per-
forms a direct contact with the antigenic peptide presented by the
MHC (Rock et al, 1994).
The concept of preferential TCR usage in autoimmune dis-
eases stems from the observation that antigen-speci¢cTcells from
experimental autoimmune encephalomyelitis express Vb8.2 and
Jb2.5 (Acha-Orbea et al, 1988; Urban et al, 1988; Zamvil et al,
1988). Subsequently, preferential TCR usage has been reported in
other autoimmune animal models, such as Vb8.1 and Vb8.2 in
MRL-lpr/lpr lupus mice (Singer et al, 1986); Vb8.2, Vb10, and
Vb12 in experimental autoimmune myocarditis (Matsumoto
et al, 2000); Vb6 in experimental autoimmune myasthenia gravis
(Infante et al, 1992); and Vb6, Vb8.2, or Va13 in the non-insulin
dependent diabetes mouse model (Edouard et al, 1993; Yang et al,
1996; Simone et al, 1997). Despite these ¢ndings, preferential usage
of TCR genes in human autoimmune diseases is still debated
(Wilson et al, 1993). It seems that TCRs of autoantigen-speci¢c T
cells have greater diversity with frequent oligoclonal selection
but rarely demonstrate monoclonal gene preference. In skin
disorders, there is evidence that disease-related T cells might pre-
ferentially utilize particular TCR genes, such as T cells from pa-
tients with psoriasis (Chang et al, 1995;Vekony et al, 1997), alopecia
areata (Szafer et al, 1995), and bullous pemphigoid (Michalaki et al,
1993). Recently, several reports demonstrate that there is consider-
able diversity in TCR usage in clonal response to myelin basic
protein 83^99 in patients with multiple sclerosis (Richert et al,
1995; Hemmer et al, 1997). Nevertheless, there are studies identify-
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ing a conserved TCR usage in multiple sclerosis patients that
exhibit HLA-DR2 restriction (Zang et al, 1998) and in patients
with stable disease over time (Uccelli et al, 1998). These ¢ndings
have prompted investigators to conduct clinical trials using pep-
tides derived fromVb5.2 or Vb6 to immunize individuals in the
hope of mounting a response against T cells responsible for trig-
gering the development of multiple sclerosis (Howell et al, 1989;
Vandenbark et al, 1989; O⁄ner et al, 1991; Bourdette et al, 1998).
Perhaps the most convincing preferential TCR usage in human
autoimmune disease comes from the identi¢cation of Vb7 in pa-
tients su¡ering from type I diabetes (Conrad et al, 1994). The ex-
pansion of these T cells may be due to the involvement of an
endogenous superantigen in the development of this disease. In
summary, these studies provide insight into whether autoim-
muneTcells indeed express certainTCR and whether TCR ther-
apy can be practically applied in clinical trials to block or prevent
the development of autoimmune diseases.
Pemphigus vulgaris (PV) is a cutaneous autoimmune disease
characterized by circulating autoantibodies against desmoglein-3
(Dsg3) (Amagai et al, 1991), a 130-kDa desmosomal glycoprotein,
and suprabasilar blisters in the epidermis (Lever, 1965). Previously,
we demonstrated that the majority of T cells from patients with
PV proliferate in response to three Dsg3 peptides on the ectodo-
main of Dsg3 (Lin et al, 1997). It appears that the proliferation
response of these T cells to Dsg3 fragments is restricted to HLA-
DRB10402 or 1401 allele. Further analysis of these Tcells reveals
that they express a CD4 memoryT cell phenotype and produce a
Th2-like cytokine pro¢le, suggesting that they belong to a subset
of T cells supporting the production of antibodies. The detailed
Dsg3 epitopes and structures of TCR of these T cells, however,
are not yet understood. Because we found that PV T cells target
multiple antigenic fragments, we hypothesize that autoimmuneT
cells in PV patients probably mount a polyclonal response against
Dsg3. It is also possible, however, that there is a limited TCR
gene usage inT cell clones responding to a single Dsg3 fragment.
The purpose of this study was to utilize a panel of well-de¢ned
PCR primer sets (Heufelder et al, 1995) to investigate whether
these PV T cells preferentially express a certain TCRVa or Vb
chain and to further illustrate the detailed Dsg3 epitopes recog-
nized by PV T cells. We believe that our results presented here
provide further understanding of the cellular autoimmune
responses underlying the development of PV. The human subject
protocol in this study have been approved by the MCW.
MATERIALS ANDMETHODS
Development of Dsg3-speci¢c T cell clones The development of
Dsg3-speci¢c T cell clones was described previously (Lin et al, 1997). The
HLA-DR of patients that we derived Dsg3-speci¢c T cells from are 0401/
1401 for patient EG, 1401 for patient NW, 0701/1401 for patient WAF, and
1401/1501 for patient MLC. Brie£y, three Dsg3 fragments that cover part
of Dsg3 ectodomain were used to derive T cell clones from four PV
patients by repeated in vitro stimulation. In total, four clones responding to
Dsg3 (amino acids (AA) 145^192), six clones responding to Dsg3 (AA 240^
303), and seven clones responding to Dsg3 (AA 570^614) were used in this
study. The antigen speci¢city of these T cell clones was veri¢ed by
proliferation assay as described (Lin et al, 1997). To determine the epitope
responsible for activating T cell clones speci¢cally responding to Dsg3, a
series of 15-amino-acid peptides with a 3-amino-acid o¡set covering
these three Dsg3 fragments were synthesized (Chiron Mimotopes,
Raleigh, NC) and used in the proliferation assay. The last peptide of each
series, however, contains only 1 amino acid. Brie£y, T cells were cultured
with irradiated autologous EBV cells pulsed with 20 mg per mL Dsg3
peptides for 5 d. At the last 18 h of incubation, cells were pulsed with
1 mCi per well of [3H]thymidine before cell harvesting (Inotech
Biosystems International, Rockville, MD). A cell proliferation of three or
more stimulation index over the background is recognized as a positive
response to the Dsg3 peptide.
Stimulation index¼ cpm of Tcells cultured with peptides/cpm of Tcells
cultured with medium.
Total RNA extraction and cDNA synthesis A total of 2  106 Tcells
were ¢rst harvested after 7 d of in vitro culture in the presence of antigen
and irradiated antigen-presenting cells. Total RNA was extracted from T
cell clones using TRIzol reagent according to the protocol provided by
manufacturer (Invitrogen, Carlsbad, CA). The ¢rst-strand cDNAs were
subsequently synthesized by reverse transcription using Thermoscript
cDNA synthesis kit and oligo(dT) primer (Invitrogen). The quantity of
cDNA yielded from each clone was determined by a spectrophotometer
(Beckman Coulter, Fullerton, CA).
RT-PCR-based TCR gene analysis The expression of TCR b chain
genes was analyzed using a speci¢c 50 -primer for each of the 24 Vb
Table I. Dsg3 responses and TCR gene usage of PV Tcell clones
T cell responsesa TCRb
Clones Dsg3 (AA 145^192) Dsg3 (AA 240^303) Dsg3 (AA 570^614) Epitopec BV BJ AV AJ
NW1 5.2 (^) (^) AA 163^177 b13 JB1.2 a8, 22 11, 4
WAF1 4.5 (^) (^) AA 163^177 b13 JB2.5 a16, 22 42, 56
EG3.23 5.5 (^) (^) AA 163^177 b13 JB1.5 a16, 22 nd, 39
EG3.26 6.0 (^) (^) AA 163^177 b13 JB1.2 a10, 22 26, 4
EG4.6 (^) 8.2 (^) AA 285^299 b7 JB2.3 a10 30
EG4.18 (^) 3.2 (^) AA 285^299 b7 JB2.3 a10 22
EG4.21 (^) 3.0 (^) AA 264^278 b8 JB1.3 a17, 19 41, 30
EG4.22 (^) 15.5 (^) AA 264^278 b8 JB1.1 a10 nd
EG4.25 (^) 5.0 (^) AA 285^299 b7 JB2.3 a10 22
MLC2 (^) 3.3 (^) AA 285^299 b7 JB2.7 a8, 22 nd, 52
EG6.3 (^) (^) 3.0 AA 576^590 b17 JB1.1 a7, 22 24, 56
EG6.5 (^) (^) 4.0 AA 576^590 b17 JB2.1 a8 3
EG6.10 (^) (^) 3.2 AA 579^593 b12 JB2.1 a7, 16 11, 40
EG6.21 (^) (^) 6.0 AA 576^590 b17 JB1.1 a16 10
EG6.23 (^) (^) 10.0 AA 585^599 b9 JB2.2 a8 nd
EG6.25 (^) (^) 5.5 AA 576^590 b17 JB1.1 a6, 10 58, 22
MLC3 (^) (^) 3.9 AA 576^590 b17 JB2.1 a10 44
a The proliferative responses of PV Tcell clones to Dsg3 antigens are presented as stimulation index. GSTprotein was used as the negative control in these experiments.
(^), no response. HLA-DRB1 and -DQB1 alleles of PV patient WAF are 0701/1401 and 0201/0503, respectively. In patient EG, the DRB1 and DQB1 alleles are 0402/1401
and 0302/0503, respectively. Patient NW expresses DRB11401/1401 and DQB10503/0503, while patient MLC expresses DRB11401/1501 and DQB10503/0602.
b TCR gene usage of T cell clones was determined by RT-PCR using speci¢c Vb or Va 50 -primers paired with Cb or Ca 30 -primers, respectively. Usage of Jb or Ja
genes of these clones was determined by DNA sequence of PCR products. The nomenclature of TCR J a chain used in this report is based on Koop et al (1994). nd,
sequence not determined by Koop et al.
cDetailed epitopes recognized byT cell clones were determined using overlapping peptides in the proliferation assays as described under Materials and Methods.
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families (twoVb5 subfamilies,Vb5.1 andVb5.2) and a 30 -primer within the
constant region of the TCR b chain in PCR (Heufelder et al, 1995), except
that the primer sequences of Vb5.1 andVb5.2 are 50 -ATACTTCAGTGAGA
HCACAGAGA-30 and 50 -TTCCCTAACTATAGCTCTGAGCTG-30, res-
pectively. The usage of TCRVa chains of these T cell clones was analyzed
using 22 speci¢c Va primers and a 30 -primer covered the constant region
of the TCR a chain. The expected sizes of PCR products were addressed
previously (Heufelder et al, 1995).
For each PCR procedure, 50 ng of cDNA and 0.5 mM Vb-speci¢c and
Cb-speci¢c (or Va-speci¢c and Ca-speci¢c primers in the experiments of
analyzing Va chain usage) were combined in a ¢nal volume of 25 mL and
then added to Ready-To-Go PCR beads containing 1 PCR bu¡er,
1.5 mM MgCl2, 200 mM dNTP, and 1 unit of Taq DNA polymerase
(Amersham Pharmacia Biotech, Piscataway, NJ). Primers used in this
study were synthesized by Operon (Alameda, CA). PCR ampli¢cation
was carried out using 30 cycles of 931C for 60 s, 551C for 60 s, and 721C
for 60 s in the thermocycler PTC-200 (MJ Research, Incline Village, NV).
A b-actin primer set was used as the positive control of the PCR (Lin et al,
2000).The PCR products were subsequently analyzed on a 2% agarose gel,
visualized under a UV illuminator, and documented. The TCRVb gene
usage was veri¢ed by the presence of a single PCR product from a panel
of 25 Vb-Cb primer reactions, while the TCR Va gene usage was
con¢rmed by one or two products from a panel of 22 Va-Ca primer
reactions.
Cloning and sequencing of TCR Vaor b genes The PCR products
were subcloned into pCRII-TOPO vector using theTOPO TA cloning kit
(Invitrogen) and transformed into Escherichia coli strain DH5a (Invitrogen).
The bacteria clones containing the correct TCRVb (or Va) inserts were
selected using colony PCR. Subsequently, plasmid DNA was puri¢ed by
rapid plasmid miniprep system (Marligen, Ijamsville, MD) and analyzed
by EcoRI (Invitrogen) digestion for the presence of proper inserts. The
DNA sequence of the Vb (or Va) inserts were analyzed by an automatic
DNA sequencer using M13 primer and compared to reported human
TCR genes in the GenBank.
RESULTS
Determination of epitopes recognized by Dsg3-speci¢c T
cell clones Previously, we have demonstrated that T cells from
PV patients react with three Dsg3 segments covering parts of
Dsg3 ectodomain. To analyze the characteristics of these T cells,
clones were derived from these patients. Using proliferation
assays, we found that these clones speci¢cally respond to any
one of these three Dsg3 fragments (Table I). Further detailed
Dsg3 epitope mapping of these T cell clones revealed that clones
responding to Dsg3 (AA 145^192) all proliferated to epitope
Dsg3 (AA 163^177) (Fig 1A), whereas T cell clones responding
to Dsg3 (AA 240^303) proliferated either to Dsg3 (AA 285^
299) (n¼ 4) (Fig 1B) or to Dsg3 (AA 264^278) (n¼ 2) (Fig 1C).
Analyzing the epitope recognized byT cells responding to Dsg3
(AA 570^614), we found that ¢ve T cell clones proliferated to
Dsg3 (AA 576^590) (Fig 1D), one clone reacted with Dsg3 (AA
579^593), and one clone responded to Dsg3 (AA 585^599) (Table
I). All of these clones express aTh2-type memory cell phenotype
Figure1. Epitope speci¢city of T cell clones responding to Dsg3. Overlapping 15-amino-acid peptides, with a 3-amino-acid o¡set, covering Dsg3
(AA 145^192) (A), Dsg3 (AA 240^303) (B,C), and Dsg3 (AA 570^614) (D) were used to de¢ne the responsiveTcell epitopes in the proliferation assays. T cell
clones were cultured with the peptide-pulsed autologous antigen-presenting cells for 5 d. One microcurie of [3H]thymidine was added to each well during
the last 18 h of incubation, and the proliferation of T cells was determined by [3H]thymidine incorporation and reported as stimulation index. T cells
cultured with medium or mitogen PHAwere used as negative and positive controls (not shown), respectively. The proliferation responses of representative
clones were shown here. The background of T cells cultured with medium ranged from approximately 1100 to 3500 cpm.
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(i.e., secretion of IL-4 and IL-5, but not IL-2 and IFN-g, upon
activation) and respond to Dsg3 restricted to HLA-DR (not
shown).
TCR gene usage of PV Tcell clones To determine whether T
cells from PV patients responding to di¡erent Dsg3 peptides
express certain TCR, RT-PCR was employed to analyze their
Vb and Va gene usage as described under Materials and
Methods. As shown in Fig 2, it appears that all four T cell
clones from three di¡erent patients responding to Dsg3 (AA
145^192) utilized the TCRVb13 gene. Of six clones responding
to Dsg3 (AA 240^303), four of them expressed TCRVb7 and
Figure 2. Dsg3-speci¢c T cell clones
preferentially express certain TCR Vb
genes. The utilization of TCRVb genes by
T cell clones derived from PV patients were
determined by RT-PCR using speci¢c pri-
mer sets as described under Materials and
Methods. The PCR products were loaded
on a 2% agarose gel with ethidium bro-
mide, visualized under the UV translumina-
tor, and documented by photography. Lane 1,
100-bp DNA marker; lane 2^26,Vb1^4, 5.1,
5.2, and 6^24; lane 27, b-actin. The lane that
has the PCR product, except the b-actin
control, was labeled with an asterisk above.
From a total of 17 clones analyzed in this
study, 4 clones responding to Dsg3 (AA
146^192) express Vb13 gene. Of 6 clones re-
sponding to Dsg3 (AA 240^303), 4 express
Vb7, while 2 clones utilize Vb8 gene. Of 7
clones responding to Dsg3 (AA 570^614) all
express Vb17 except 2, which use Vb9 or
Vb12 gene.
Table II. TCR amino acid and nucleotide sequence alignments of PV Tcell clones responding to Dsg3 (AA 145^192)a
Clone VB VB region (N)D(N) JB region JB VA JA region JA
NW1 b13 R A S Q PA D R E LY G Y T F G S G T R LT V L 1.2 a8 T LT F G K G T M L LV S P 11
CGTGCC-
AGCCAA
CCTGCGGACA-
GGGAACTCTAT
GGCTACACCTTCGG-
TTCGGGGACCAGGTT-
AACCGTTGTA
ACCCTCACCTTTGGGAA-
GGGGACTATGCTTCT-
AGTCTCTCCA
a22 K L I F G A G T R L AV H P 4
AAGCTGATTTTTGG-
AGCAGGGACCAGGCTGGCT-
GTACACCCA
WAF1 b13 C A S S S A G T G V E T QY F G P G T R L LV L 2.5 a16 N L I F G K G T K L S V K P 42
TGTGCCA-
GCAGT
TCCGCCGGGA-
CAGGGGTCGAG
ACCCAGTACTTC-
GGGCCAGGCACGCGGCT-
CCTGGTGCTC
AATCTCATCTTTGG-
AAAAGGCACTAAACTC-
TCTGTTAAACCA
a22 K LT F G K G I T L S V R P 56
AAGCTGACATTTGG-
AAAAGGAATAACTCT-
GAGTGTTAGACCA
EG3.23 b13 C A S K A G E W Q P Q H F G D G T R L S I L 1.5 a16 K V T F G T G T K L QV I P nd
TGTGCCAGCAAG GCAGGGGAGTGG CAGCCCCAGCATTTT-
GGTGATGGGACTCGACT-
CTCCATCCTA
AAAGTTACCTTTGGAA-
CTGGAACAAAGCTCCAAG-
TCATCCCA
a22 M LT F G G G T R L M V K P 39
ATGCTCACCTTTGGA-
GGGGGAACAAGGTTAAT-
GGTCAAACCC
EG3.26 b13 C A S R G V I G Y T F G S G T R LT V V 1.2 a10 N F V F G P G T R L S V L P 26
TGTGCCAGCAGG GGGGTTATT GGCTACACCTTCGGTT-
CGGGGACCAGGTTAACCGTTGTA
AATTTTGTCTTTGGT-
CCCGGAACCAGATTGTCCGTG-
CTGCCC
a22 K L I F G A G T R L AV H P 4
AAGCTGATTTTTGGAGC-
AGGGACCAGGCTGGC-
TGTACACCCA
and, sequence not determined by Koop et al (1994).VB,TCRVb; JB, Jb chain; VA,TCRVa chain; JA, Ja chain.
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two utilized Vb8. Analysis of the TCR b chains of seven clones
responding to Dsg3 (AA 570^614) revealed that all but two clones
used TCRVb17. One of these two clones expressed Vb9 and the
other expressed Vb12 of TCR gene (Fig 2;Table I).
Interestingly, we found that Va22 was commonly utilized by
all clones responding to Dsg3 (AA 145^192), suggesting that this
group of Dsg3-speci¢c T cell clones may preferentially express
TCRVa22Vb13 to recognize a Dsg3 epitope (Table I). In clones
responding to Dsg3 (AA 240^303), it appears that Va10 gene was
predominantly expressed, whereas there was no preferential Va
expression in clones reacting with Dsg3 (AA 570^614) (Table I).
Overall, we did not observed a preferential Ja chain usage among
ourTcell clones. Ja chains of all Dsg3-speci¢cTcell clones in this
study all expressed a motif of F-G-X-G-T that is found inTCR a
chains of T cells (Koop et al, 1994).
VDJ region sequence of TCR genes utilized by PV T cell
clones responding to Dsg3 (AA 145^192) To verify the
expression of Vb and Va genes and the amino acid sequence of
these TCRs, PCR products were subcloned into TOPO vector
and transformed into bacteria hosts as described under Materials
and Methods. The colonies that contain the correct TCR cDNA
products were veri¢ed by colony PCR, selected, and ampli¢ed,
and their DNA samples were subjected to automatic DNA
sequencing. The nucleotide and amino acid sequences of TCR a
and b chain VJ or VDJ regions of T cell clones responding to
Dsg3 (AA 145^192) are demonstrated in Table II. Analyzing the
TCRaVDJ sequences, we found that the (N)D(N) regions of
these clones are three to seven amino acids in length and there is
no apparent preferential utilization of Jb chain. Interestingly, we
found that at the V^D junction of clone EG3.23 and EG3.26,
there is a G to A nucleotide substitution resulting an amino acid
replacement of lysine to arginine located at the V^D junction.
This substitution is not because of the polymorphism of Va13
but because of the result of N- or D-region nucleotide contri-
bution. Apparently, this is not uncommon at the 30 end of TCR
Va chain. Because both lysine and arginine have positively
charged R groups, this replacement is considered a conservative
substitution. In cloneWAF1, the C-terminus of theV region is the
same as EG3.23 and EG3.26 with the exception of a serine located
at theV^(N)D(N) junction instead of lysine or arginine. In clone
NW1, the last four amino acids of V chain was arginine-alanine-
serine-glutamine, which was di¡erent from the common cyst-
eine-alanine-serine-serine (CASS) combination found in other
T cell clones (Tables II, III, IV). The S to Q substitution in the
V^(N)D(N) junction of NW1 is conservative, whereas the C to
R substitution is not.
Analyzing the sequence of TCRVJ sequence, we found that all
clones responding to Dsg3 (AA 145^192) express two TCRVa
genes with theVa22 as the common one. There is no preferential
usage of TCRAJ ( J a chain) gene among these clones (Table II).
VDJ region sequence of TCR genes utilized by PV T cell
clones responding to Dsg3 (AA 240^303) In the group of T
cell clones responding to Dsg3 (AA 240^303), we identi¢ed that
two clones (EG4.21 and EG4.22) expressed Vb8 and four clones
(EG4.6, EG4.18, EG4.25, and MLC2) expressed Vb7 (Tables I,
III). When comparing the VDJ of T cell clones responding to
Dsg3 (AA 240^303), we found that EG4.6, EG4.18, and EG4.25
exhibited identical nucleotide and amino acid sequences in these
regions, suggesting that these three clones were probably derived
from the same parental cell line (Table III). Nevertheless, in clone
EG4.18, there was a K (encoded byAAA) to E (encoded by GAA)
substitution in the fourth position of the Cb region (not
shown).
When comparing the TCRVa genes expressed by this group
of T cells, we found that there are four clones utilizing Va10
genes (Tables I, III). Nevertheless, we do not consider that this
Va gene is preferentially used due to the fact that among these
four clones, three of them (EG4.6, EG.4.18, and EG4.25) are
derived from the same parental clones. Interestingly, although
EG4.6 expressed same Va chain as EG4.18 and EG4.25, but it
utilized TCRAJ30 instead of TCRAJ22 gene (Tables I, III).
The length of TCRb (N)D(N) region ranged from
two to eight amino acids in these clones with no apparent
preferential utilization of Jb chain. In clone EG4.21, the last
two amino acids in the V region were threonine (encoded by
ACC and ACA) instead of serine (encoded by AGC). Because
threonine and serine are both polar amino acids with an
Table III. TCR amino acid and nucleotide sequence alignments of PV Tcell clones responding to Dsg3 (AA 240^303)a
Clone VB VB region (N)D(N) JB region JB VA JA region JA
EG4.6 b 7 C A S S RG G AQ I T D T QY F G P G T R LT V L 2.3 a10 K I I F G K G T R L H I L P 30
TGTGCCAGCAGC AGGGGGGGGGCGC-
AAATCACAGAT
ACGCAGTATTTTGGCCCA-
GGCACCCGGCTGACAGTGCTC
AAGATCATCTTTGGAAAA-
GGGACACGACTTCATATTCTCCCC
EG4.18 b 7 C A S S RG G AQ I T D T QY F G P G T R LT V L 2.3 a10 Q LT F G S G T Q LT V L P 22
TGTGCCAGCAGC AGGGGGGGGGCGC-
AAATCACAGAT
ACGCAGTATTTTGGCCCAGG-
CACCCGGCTGACAGTGCTC
CAACTGACCTTTGGATCTGGG-
ACACAATTGACTGTTTTACCT
EG4.21 b 8 C AT T N T G N T I Y F G E G S W LT V V 1.3 a17 A L N F G K G T S L LV T P 41
TGTGCCACCACA AACACT GGAAACACCATATATTTTGGAG-
AGGGAAGTTGGCTCACTGTTGTA
GCACTCAACTTCGGCAAAGGCA-
CCTCGCTGTTGGTCACACCC
a19 K I I F G K G T R L H I L P 30
AAGATCATCTTTGGAAAAGGGA-
CACGACTTCATATTCTCCCC
EG4.22 b 8 C A S S N Y R D G G T E A F F G Q G T R LT V V 1.1 a10 K V T F G T G T K L QV I P nd
TGTGCCAGCAGT AATTACAGGGA-
CGGGGGC
ACTGAAGCTTTCTTTGGACAA-
GGCACCAGACTCACAGTTGTA
AAAGTTACCTTTGGAACTGG-
AACAAAGCTCCAAGTCATCCCA
EG4.25 b 7 C A S S RG G AQ I T D T QY F G P G T R LT V L 2.3 a10 Q LT F G S G T Q LT V L P 22
TGTGCCAGCAGC AGGGGGGGGGCGCA-
AATCACAGAT
ACGCAGTATTTTGGCCCAGG-
CACCCGGCTGACAGTGCTC
CAACTGACCTTTGGATCTGGG-
ACACAATTGACTGTTTTACCT
MLC2 b 7 C A S S QV D P P E QY F G P G T R LT V T 2.7 a8 A I S F G A G T T V T V R A nd
TGCGCCAGCAGC CAAGTCGACCCTCCC GAGCAGTACTTCGGGCCGG-
GCACCAGGCTCACGGTCACA
GCAATCAGCTTTGGAGCC-
GGAACCACAGTAACTGTAAGAGCA
a22 K LT F G Q G T I LT V H P 52
AAGCTGACATTTGGACAAGGG-
ACCATCTTGACTGTCCATCCA
and, sequence not determined by Koop et al (1994).VB,TCRVb; JB, Jb chain; VA,TCRVa chain; JA, Ja chain.
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uncharged R group, this is considered a conservative amino acid
substitution.
VDJ region sequence of TCR genes utilized by PV T cell
clones responding to Dsg3 (AA 570^614) In clones
responding to Dsg3 (AA 570^614), we found that the length of
(N)D(N) regions varied from four to nine amino acids, and
there was no obvious preferential utilization of Jb chain
observed (Table IV). Again, the identical TCR VDJ sequences
(at both nucleotide and amino acid levels) of clones EG6.3,
EG6.21, and EG6.25 suggests that they were derived from a
common parental cell line (Table IV). The identical nucleotide
sequences in these clones was not due to DNA sequencing
errors because PCR products from several clones have been
independently subcloned and analyzed (not shown). None of
these clones, however, expressed a particular Va chain (Tables I,
TableV. Partial PV Tcell clone TCRVDJ amino acid sequence alignmenta
Clone Vb region (N)D(N) region Jb region Cb region
NW1 TSVYFRASQ PADRELY GYTFGSGTRLTVL EDLNKVFPPEVA
WAF1 TSVYFCASS SAGTGVE TQYFGPGTRLLVL EDLKNVFPPEVA
EG3.23 TSVYFCASK AGEW QPHFGDGTRLSIL EDLNKVFPPEVA
EG3.26 TSVYFCASR GVI GYTFGSGTRLTVV EDLNKVFPPEVA
EG4.6 SALYLCASS RGGAQITD TQYFGPGTRLTVL EDLKNVFPPEVA
EG4.18 SALYLCASS RGGAQITD TQYFGPGTRLTVL EDLENVFPPEVA
EG4.21 SAVYFCATT NT GNTIYFGEGSWLTVV EDLNKVFPPEVA
EG4.22 SAVYFCASS NYRDGG TEAFFGQGTRLTVV EDLNKVFPPEVA
EG4.25 SALYLCASS RGGAQITD TQYFGPGTRLTVL EDLKNVFPPEVA
MLC2 SALYLCASS QVDPP EQYFGPGTRLTVT EDLKNVFPPEVA
EG6.3 TAFYLCASS HQKGR AFFGQGTRLTVV EDLNKVFPPEVA
EG6.5 TAFYLCAST LRLAGGRNN EQFFGPGTRLTVL EDLKNVFPPEVA
EG6.10 TSVYFCAIS AATGY EQFFGPGTRLTVL EDLKNVFPPEVA
EG6.21 TAFYLCASS HQKGR AFFGQGTRLTVV EDLNKVFPPEVA
EG6.23 SAVYFCASS QVEN TGELFFGEGSRLTVL EDLKNVFPPEVA
EG6.25 TAFYLCASS HQKGR AFFGQGTRLTVV EDLNKVFPPEVA
MLC3 TAFYLCASS FGAGGYN EQFFGPGTRLTVL EDLKNVFPPEVA
aThe amino acids showing identity are underlined; the conserved amino acids are in bold.
Table IV. TCR amino acid and nucleotide sequence alignments of PV Tcell clones responding to Dsg3 (AA 570^614)a
Clone VB VB region (N)D(N) JB region JB VA JA region JA
EG6.3 b17 C A S S H Q KG R A F F G Q G T R LT V V 1.1 a7 K L Q F G A G T QV V V T P 24
TGTGCCAGTAGT CACCAAAAAGGACGG GCTTTCTTTGGACAAGGCA-
CCAGACTCACAGTTGTA
AAATTGCAGTTTGGAGCAGGGA-
CCCAGGTTGTGGTCACCCCA
a22 K LT F G K G I T L S V R P 56
AAGCTGACATTTGGAAAAGGAA-
TAACTCTGAGTGTTAGACCA
EG6.5 b17 C A S T L R L A G G R N N E Q F F G P G T R LT V L 2.1 a8 K I I F G S G T R L S I R P 3
TGTGCCAGTACC CTGAGGCTAGCGG-
GAGGGAGGAACAAT
GAGCAGTTCTTCGGGCCAGG-
GACACGGCTCACCGTGCTA
AAGATAATCTTTGGATCAGGGA-
CCAGACTCAGCATCCGGCCA
EG6.10 b12 C A I S A AT G Y E Q F F G P G T R LT V L 2.1 a7 T LT F G K G T M L LV S P 11
TGTGCCATCAGT GCAGCTACAGGGTAT GAGCAGTTCTTCGGGCCAGG-
GACACGGCTCACCGTGCTA
ACCCTCACCTTTGGGAAGGGGA-
CTATGCTTCTAGTCTCTCCA
a16 K Y I F G T G T R L K V L A 40
AAATACATCTTTGGAACAGGCA-
CCAGGCTGAAGGTTTTAGCA
EG6.21 b17 C A S S H Q KG R A F F G Q G T R LT V V 1.1 a16 K LT F G T G T Q L K V E L 10
TGTGCCAGTAGT CACCAAAAAGGACGG GCTTTCTTTGGACAAGGCACC-
AGACTCACAGTTGTA
AAACTCACCTTTGGGACAGGCA-
CTCAGCTAAAAGTGGAACTC
EG6.23 b9 C A S S QV E N T G E L F F G E G S R LT V L A L I F G K G T T L S V S S nd
TGTGCCAGCAGC CAGGTAGAGAAC ACCGGGGAGCTGTTTTTTG-
GAGAAGGCTCTAGGCTGACCG-
TACTG
2.2 a8
GCTCTGATCTTTGGGAAGGGAAC-
CACCTTATCAGTGAGTTCC
EG6.25 b17 C A S S H Q KG R A F F G Q G T R LT V V 1.1 a6 R LT F G E G T Q LT V N P 58
TGTGCCAGTAGT CACCAAAAAGGACGG GCTTTCTTTGGACAAGG-
CACCAGACTCACAGTTGTA
AGGTTGACCTTTGGGGAAGGAA-
CACAGCTCACAGTGAATCCT
a10 Q LT F G S G T Q LT V L P 22
CAACTGACCTTTGGATCTGGGAC-
ACAATTGACTGTTTTACCT
MLC3 b17 C A S S F G A G G Y N E Q F F G P G T R LT V L 2.1 a10 D M R F G A G T R LT V K P 44
TGTGCCAGTAGT TTTGGAGCGGGA-
GGTTACAAT
GAGCAGTTCTTCGGGCCAGG-
GACACGGCTCACCGTGCTA
GACATGCGCTTTGGAGCAGGG-
ACCAGACTGACAGTAAAACCA
and, sequence not determined by Koop et al (1994).VB,TCRVb; JB, Jb chain; VA,TCRVa chain; JA, Ja chain.
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IV). These three related clones plus two other unrelated clones
(EG6.23 and MLC3) exhibited the CASS common sequence at
the C-terminus at the V region. Also, there is no preferential
usage of TCR a chain genes could be observed among these T
cell clones (Table IV).
There was no apparent association between the strength of
proliferative responses to Dsg3 antigens and the utilization of
TCRb in these T cell clones (Table I), but we did observe that
the response to Dsg3 epitopes is determined by the expression
of TCRVb chain (Table I). The amino acid sequence alignment
of TCRVb VDJ of these PV Tcell clones is shown inTableV. It
appears that there were two regions, C-terminus of Vand the J^C
junction, within the TCRb chains of these T cell clones that are
highly conserved.
DISCUSSION
The rearrangement of VDJ genes is required for B and T cells to
express functional Ig or TCR, respectively. Several molecular me-
chanisms are involved in the rearrangement of TCRVDJ genes,
including multiple germline gene segments, combinatorial diver-
sity, junctional diversity, and gene conversion (Schatz, 1997).
Quite often, an additional nucleotide is added in the junctional
regions of V^D^J, further increasing the diversity of TCR or Ig
(Desiderio et al, 1984; Gil¢llan et al, 1993; Komori et al, 1993).
Because of these recombinatorial mechanisms, the mammalian
immune system is capable of producing a great repertoire of Ig
and TCR counteracting the equally diversi¢ed antigenic chal-
lenges in the environment.
Importantly, the rearrangement of the TCR b chain genes fol-
lows the rule of allelic exclusion (Uematsu et al, 1988), whereas the
rearrangement of its counterpart a chain does not (Malissen et al,
1992; Padovan et al, 1993). This phenomenon leaves a T cell clone
to express only a single TCR b chain to pair with either one or
two TCR a chain (Casrouge et al, 2000). It is believed that the
antigenic speci¢city of a T cell is maintained by a set of TCR;
hence, a detailed structure and sequence analysis of TCR b chain
and the investigation of a possible preferential Vb chain usage in
autoimmuneTcells may reveal the key epitope(s) involved in the
development of autoimmune diseases (Moss and Bell, 1999).
In this report, we showed that T cells responding to Dsg3 are
polyclonal, but within groups of Dsg3-fragment-speci¢c T cells,
a preferential TCR usage can be observed. All T cell clones react-
ing with Dsg3 (AA 145^192) expressed Vb13. Because TCRVb
was shown to govern the peptide binding, it is possible that all
these T cell clones recognize a single epitope. This assumption
was made based on the evidence that clones from this group all
proliferated in response to a 15-amino-acid peptide, Dsg3 AA
163^177. Three patients from whom we derived these clones all
exhibit the PV-restricted HLA haplotypes (Ahmed et al, 1991),
and the antigenic responses of T cells are all restricted to these
HLA-DR alleles. Analysis of TCR a chains expressed by these
fourTcell clones, we found that they all produced twoVa chains,
but with the Va22 as a common TCR. It is possible that these
clones respond to Dsg3 (AA163-177) by using TCRVa22Vb13.
Nevertheless, this study certainly does not rule out the possibility
that other TCRVa chains may participate in the recognition of
the Dsg3 for these T cells.
In the group of T cell clones responding to Dsg3 (AA
240^303), clones expressing TCRVb8 responded to Dsg3 (AA
264^278), whereas clones expressing Vb7 proliferated to Dsg3
(AA 285^299). These results suggest that the expression of TCRb
determines the epitopes recognized by T cells. Interestingly, we
found that clones EG4.6, EG4.18, and EG4.25 all expressed iden-
tical TCR b chain DNA sequence. Because the TCR b chain was
formed in the pre-T cells, while the TCR a chain was rearranged
in the double-positive T cell stage, we therefore, conclude that
these three clones are derived from a clonal progenitor regardless
of whether they express same (EG4.18 and EG4.25) or di¡erent
(EG4.6) TCR a chains. Interestingly, clone EG4.18 is identical in
sequence to that of EG4.6 and EG4.25 with the exception of a
glutamic acid (encoded by GAA) to lysine (encoded by AAA)
substitution at the fourth position of the Cb region.
In clones responding to Dsg3 (AA 570^614), we found that
Vb17 T cell clones responded to Dsg3 (AA 576^590) (n¼ 4),
Vb12 T cell clone responded to Dsg3 (AA 579^593) (n¼1),
whereas Vb9 T cell clone proliferated to Dsg3 (AA 585^599)
(n¼1). These results further support that the Dsg3 epitope
recognized by a T cell is related to the expression of TCRVb
chain. These three epitopes partially overlap with a combined
length of 24 amino acids (AA 576^599). It is worth of noting
that MHCII on an antigen-presenting cells is capable of present-
ing a peptide ranging from 12 to 24 amino acids to a TCR;
therefore, our data suggest that all these clones might respond
to a common epitope, Dsg3 (AA 576^599), despite a minor
di¡erence of the epitopes. Again, the identical VDJ sequences
(at both nucleotide and amino acid levels) of clones EG6.3,
EG6.21, and EG6.25 suggest that they are probably derived
from a common parental cell line, despite each clone’s distinct
Va chain(s).
When comparing TCRVb sequences of PV T cell clones, we
found that the amino acid sequence of cysteine-alanine-serine-
serine at the V^D junction is common to almost all of the clones
available for this study. This result was also identi¢ed in T cells
from patients with endemic pemphigus foliaceus (Moesta et al,
2002). Another interesting observation from this study is the sin-
gle nucleotide substitution that occurred in the fourth and ¢fth
codons in the Cb region of T cell clones resulting in a KN to
NK substitution. Clones NW1, EG3.23, 3.26, 4.21, 4.22, 6.3, 6.21,
and 6.25 express asparagine (N) (coded by AAC) and lysine (K)
(coded by AAG) at position four and ¢ve of the Cb region,
whereas clones WAF1, EG4.6, 4.25, 6.5, 6.10, 6.23, MLC2, and
MLC3 express lysine (K) (coded by AAA) and asparagine (N)
(coded by AAC) at the corresponding positions. These ¢ndings
further reveal the complexity of the recombinational diversity in
the construction of the TCR.
When aligning amino acid sequences of V^D^J^C regions, we
¢nd that the areas in the carboxyl terminus of V and J and the N
terminus of the C regions are highly conserved for all T cell
clones analyzed, similar to other ¢ndings, suggesting that these
regions form the anchor of the antigen binding site on TCR,
allowing the VDJ junctional area to form physical contact with
the Dsg3 peptides. This level of conservation in the TCRs of
these clones is not unexpected in light of the ¢nding that all of
them respond to Dsg3 antigens with a restriction to HLA-DRB1
alleles (Lin et al, 1997). At present, we do not know which key
amino acids in the VDJ junction of TCRs govern the binding
to the Dsg3 antigenic peptides.
Previously, in our analysis of the TCR expression of 17 T cell
clones responding to desmoglein-1, we identi¢ed that these
clones display oligoclonality and there is a potential preferential
usage of TCRVb5.1 (n¼ 5). Nevertheless, theTCR usage among
these clones is not completely restricted to a given gene family.
Interestingly, in three clones that respond to desmoglein-1 (AA
412^426), none of them showed a restricted usage of TCRVb
chain. This result is certainly di¡erent from our report here de-
monstrating that there is a restricted utilization of TCRVb re-
sponding to a particular Dsg3 peptide in PV T cell clones.
Moreover, TCR gene usage varies within a given patient with
pemphigus foliaceus, indicating that disease induction and/or
progression is not dependent on only one set of TCR gene seg-
ments.The latter conclusion is also in agreement with our current
¢nding in PV. It has been documented that suprabasilar lesions in
PV patients are limited to mucosal tissue, but spread to skin later
with the appearance of anti-desmoglein-1 autoantibodies. It is as-
sumed that epitope spreading may relate to the development of
cutaneous lesions in mucocutaneous PV patients. It is not clear
whether Dsg3-speci¢c T cells from patients with mucosal PV ex-
press a distinct TCR than those from mucocutaneous PV. Further
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knowledge in this area would allow us to assess whether disease
evolution and epitope spreading in PV patients are associated
with involvement of di¡erent TCR-speci¢c T cell clones. A
vigorous investigation, however, is required to analyze the
possibility of designing a therapeutic reagent speci¢cally target-
ing these T cells.
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